Correlation Between Blueprint Medicines and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Agios Pharm, you can compare the effects of market volatilities on Blueprint Medicines and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Agios Pharm.
Diversification Opportunities for Blueprint Medicines and Agios Pharm
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Blueprint and Agios is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Agios Pharm go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Agios Pharm
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.76 times more return on investment than Agios Pharm. However, Blueprint Medicines Corp is 1.32 times less risky than Agios Pharm. It trades about 0.08 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.04 per unit of risk. If you would invest 9,253 in Blueprint Medicines Corp on November 2, 2024 and sell it today you would earn a total of 2,152 from holding Blueprint Medicines Corp or generate 23.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Blueprint Medicines Corp vs. Agios Pharm
Performance |
Timeline |
Blueprint Medicines Corp |
Agios Pharm |
Blueprint Medicines and Agios Pharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Blueprint Medicines and Agios Pharm
The main advantage of trading using opposite Blueprint Medicines and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Agios Pharm vs. Surrozen | Agios Pharm vs. Armata Pharmaceuticals | Agios Pharm vs. Pasithea Therapeutics Corp | Agios Pharm vs. Aditxt Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |